A new "platinumg" standard for bone grafting: Autogenous stem cells

Implant Dentistry

Volumn 14, Issue 4, 2005, Pages 322-327

  Soltan, Muna ^a   Smiler, Dennis G ^a   Gailani, Fawaz ^b  

^a Kaiser Permanente ^*  (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Autogenous bone marrow aspirate; Bone graft; Bone marrow; Stem cells

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; HUMAN; METHODOLOGY; MULTIPOTENT STEM CELL; PHYSIOLOGY; STANDARD; STEM CELL; TRANSPLANTATION;

ADULT; BONE MARROW TRANSPLANTATION; HUMANS; MULTIPOTENT STEM CELLS; STEM CELLS; TISSUE AND ORGAN HARVESTING;

EID: 33644875751     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000190419.04705.ef     Document Type: Article

References (48)

1. Pfeiffer CA. Development of bone from transplanted marrow in mice. Anat Rec. 1948;102:225.
2. Friedenstein AJ. Determined and inducible osteogenic precursor cells. In: Sognaes R, Vaughan J, eds. Hard Tissue Growth, Repair, and Remineralization. Ciba Foundation Symposium II. New York, NY: Elsevier; 1973:169-185.
3. Nade S. Clinical applications of cell function in osteogenesis: A re-appraisal of bone graft surgery. Ann R Coll Surg Engl. 1979;61:189-194.
4. Friedenstein AJ, Chailakhjan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissue. Transplantation. 1974;17:331-340.
5. Burwell RG. Studies in the transplantation of bone: VII. The fresh composite homograft-autograft of cancellous bone. An analysis of factors leading to osteogenesis in marrow transplants and in marrow-containing bone grafts. J Bone Joint Surg. 1964;466:110-140.
6. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic transplants of bone marrow. Analysis of precursor cells of osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-247.
7. Bianco P, Robey PG. Marrow stromal cells. J Clin Invest. 2000;105:1663-1668.
8. Ashton BA, Alien TD, Howlet CR, et al. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop. 1980;151:294-307.
9. Tuli R, Tuli S, Nandi S, et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells. 2003;21:681-693.
10. Mariani SM. Conference report-Stem cells and tissue engineering: Dreaming things that never were. Highlights of the American Society of Gene Therapy 7th Annual Meeting; June 2-6, 2004, Minneapolis, MN. MedGenMed. 2004;6:1-8.
11. Barclay L. Bone marrow stem cells heal wounds. Available at: http://www. medscape.com/viewarticle1452908: April 24, 2003. Arch Dermatol. 2003;139:510-516.
12. Verfaillie C, Schwartz R, Reyes M, et al. Unexpected potential of adult stem cells. Ann N Y Acad Sci. 2003;996:231-234.
13. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003;102:3483-3493.
14. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
15. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone-marrow-derived stem cell. Cell. 2001;105:369-377.
16. Dominici M, Pritchard G, Garlits JE, et al. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA. 2004;101:11761-11766.
17. Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003;100:15877-15882.
18. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257.
19. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hematology. 2000;32:11-16.
20. Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18:213-226.
21. Long MW. Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001;27:677-690.
22. Horwitz EM, Prockop DJ, Gordon PL, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001;97:1227-1231.
23. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone-marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
24. Smiler DS. Bone grafting: Materials and modes of action. Pract Periodontics Aesthet Dent. 1996;8:413-416.
25. Rosen V, Theis S. The BMP proteins in bone formation and repair. Trends Genet. 1992;8:97-102.
26. Sampath TK, Reddi AH. Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci USA. 1983;80:6591-6595.
27. Wittbjer J, Palmer B. Osteogenetic activity in composite grafts of demineralized compact bone and marrow. Clin Orthop. 1983;173:229-238.
28. Wozney JM. The bone morphogenic protein family and osteogenesis. Mol Reprod Dev. 1992;32:160-167.
29. Muthukumaran N, Ma S, Reddi A. Dose dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Collagen Relat Res. 1988;8:433-441.
30. Burchard H. Biology of bone transplantation. Orthop Clin North Am. 1987;18:187-196.
31. Lindholm TS, Nilsson OS. Extraskeletal and intraskeletal new bone formation induced by demineralized bone matrix combined with marrow cells. Clin Orthop. 1982;171:251-255.
32. Kawamura M, Urist MR. Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix non-collagenous proteins. Clin Orthop. 1988;236:240-248.
33. Kalfas IH. Principles of bone healing [abstract], Neurosurg Focus. 2001;10:1-8. Abstract 4.
34. Connolly JF, Guse R, Lippiello L, et al. Development of an osteogenic bone marrow preparation. J Bone Joint Surg. 1989;3:276-282.
35. Connolly JF, Guse R, Tiedeman J, et al. Autologous marrow injection for the delayed unions of the tibia: A preliminary report. J Orthop Trauma. 1989;3:276-282.
36. Muschler GF, Midura RJ. Connective tissue progenitors: Practical concepts for clinical applications. Clin Orthop Relat Res. 2002;395:66-80.
37. Boden SD. Bone graft substitutes for lumbar spine fusion. Available at: http://www.Spine-health.com. Accessed 2001.
38. Long MW, William JL, Mann KG. Expression of human bone-related proteins in the hematopoietic microenvironments. J Clin Invest. 1990;86:1387-1395.
39. Long MN, Robinson JA, Ashcroft SA, et al. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest. 1995;95:881-887.
40. Summers BN, Eisenstein SM. Donor site pain from the ilium. J Bone Joint Surg. 1989;71B:677-680.
41. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: The influence of aspiration volume. J Bone Joint Surg. 1997;19:1699-1707.
42. Fleming J, Cornell CN, Muschler GF. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am. 2000:31:357-374.
43. Seitz WH Jr, Froimson AL, Leb RB. Autogenous bone marrow and allograft replacement of bone defects in the hand and upper extremities. J Orthop Trauma. 1992;6:36-42.
44. Betz RR. Limitations of autograft and allograft: New synthetic solutions. Orthopedics. 2002;25:S561-S570.
45. Helm GA, Dayoub H, Jane JA. Bone graft substitutes for the promotion of spinal arthrodesis. Neurosurg Focus. 2001;10:1-7.
46. Salgado A, Coutinho OP, Reis RL Bone tissue engineering: State of the art and future trends. Macromol Biosci. 2004;4:743-765.
47. Muschler GF, Nakamoto C, Grifith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg. 2004;86-A:1541-1558.
48. Bauer TW, Muschler GF. Bone graft materials. Clin Orthop Relat Res. 2000;371:10-27.